Shared on 01 Nov 25

Fair value Increased 3.76%

Elevance Health's analyst price target has increased by approximately $14 to $389. Analysts cite firmer profit margin expectations, even though the managed care sector continues to face challenges to revenue growth.

Shared on 17 Oct 25

Fair value Increased 3.78%

AI-Enabled Analytics And Value-Based Care Will Ensure Future Stability

Analysts have raised their price target for Elevance Health by approximately $14 to $375. This reflects increased earnings visibility and expectations for a sector rotation into healthcare, despite ongoing margin pressures in certain business lines.

Shared on 03 Oct 25

Fair value Decreased 2.44%

AI-Enabled Analytics And Value-Based Care Will Ensure Future Stability

Analysts have reduced their average price target for Elevance Health by $9 to $361. They primarily cite persistent Medicaid challenges, mixed earnings commentary, and a more uncertain cost environment as key drivers of the revision.

Shared on 04 Sep 25

Fair value Increased 0.54%

AI-Enabled Analytics And Value-Based Care Will Ensure Future Stability

Following disappointing Q2 results and a significant EPS guidance cut for 2025, analysts remain cautious on Elevance Health due to earnings uncertainty and operational risks—despite some offsetting segmental strengths and longer-term positives—resulting in an unchanged consensus price target of $368.44. Analyst Commentary Bearish analysts lowered price targets following Elevance Health’s Q2 report, citing a larger-than-expected EPS guidance cut for 2025, lingering questions about the true earnings floor, and persistent volatility in cost trends.

Shared on 07 May 25

Fair value Decreased 27%